Public Citizen Re-Petitions FDA To Withdraw Obesity Drug Meridia
Executive Summary
Public Citizen has renewed its call for FDA to ban Abbott's obesity drug Meridia (sibutramine) following the release of preliminary results of a 10,000 patient study that showed the drug had a slightly higher rate of cardiovascular events